ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,610Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 2456

$884K Total Retail Price of All Prescriptions

Rank: 61 out of 2456

439 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 439 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 10,243 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
TRAZODONE HCL 553 485 1 17
LISINOPRIL 481 421 2 1
SIMVASTATIN 434 379 3 2
LEVOTHYROXINE SODIUM 422 362 4 4
FUROSEMIDE 357 326 5 8
DIVALPROEX SODIUM 323 247 6 51
METOPROLOL TARTRATE 318 292 7 10
OMEPRAZOLE 295 229 8 3
CITALOPRAM HBR 289 227 9 14
OLANZAPINE 274 235 10 57
CLOZAPINE 264 179 11 75
AMLODIPINE BESYLATE 253 212 12 5
MIRTAZAPINE 250 248 13 29
WARFARIN SODIUM 244 232 14 9
RISPERIDONE 241 203 15 50
HYDROCHLOROTHIAZIDE 194 172 16 7
QUETIAPINE FUMARATE 193 146 17 47
ATENOLOL 183 155 18 6
NAMENDA 175 175 19 42
DONEPEZIL HCL 174 174 20 23
GABAPENTIN 146 100 21 16
IPRATROPIUM-ALBUTEROL 142 133 22 85
TAMSULOSIN HCL 136 107 23 32
FLUOXETINE HCL 129 82 24 45
INSULIN SYRINGE 126 111 25 72
ATORVASTATIN CALCIUM 122 90 26 12
METFORMIN HCL 121 60 27 11
LANTUS 117 100 28 44
NOVOLOG 106 92 29 100
RANITIDINE HCL 99 77 30 31
CARBIDOPA-LEVODOPA 97 85 31 82
LEVETIRACETAM 86 51 32 90
POTASSIUM CHLORIDE 84 74 33 33
PANTOPRAZOLE SODIUM 83 57 34 37
HUMALOG MIX 75-25 77 77 35 258
CYMBALTA 76 57 36 65
HUMALOG 73 72 37 123
CIPROFLOXACIN HCL 73 70 37 87
ADVAIR DISKUS 72 42 39 36
ABILIFY 71 56 40 95
PROAIR HFA 70 19 41 22
OXCARBAZEPINE 67 67 42 190
CRESTOR 67 64 42 25
LEVEMIR 65 57 44 174
SEROQUEL 65 47 44 102
DIVALPROEX SODIUM ER 63 38 46 178
FLUVOXAMINE MALEATE 62 62 47 230
BUPROPION HCL SR 62 44 47 119
POLYETHYLENE GLYCOL 3350 62 45 47 64
NYSTOP 62 53 47 125
BENZTROPINE MESYLATE 61 52 R 51 126
LIDODERM 59 38 52 58
TRAMADOL HCL 59 53 52 24
SPIRIVA 59 29 52 43
LITHIUM CARBONATE 58 58 55 185
ALLOPURINOL 57 38 56 27
BACLOFEN 56 39 57 112
METOPROLOL SUCCINATE 56 48 57 13
CLOPIDOGREL 55 51 59 55
LAMOTRIGINE 54 46 60 120
LOVASTATIN 54 32 60 34
OXYCODONE HCL 53 15 S2 62 38
LACTULOSE 53 38 62 88
FAMOTIDINE 51 51 64 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.